ARTLVSXXII• 28 Days (Normalized)
ARTL vs XXII (Artelo Biosciences Inc. vs 22nd Century Group Inc.)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-30.37%
Artelo Biosciences Inc.
Normalized Baseline0.00%
XXII Performance $1.33
-43.16%
22nd Century Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ARTL LEADS
+12.79 pts
ARTL outperforming by 12.79 percentage points
ARTLXXII
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL XXII
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(17 dates)
| Date | ARTL Price | ARTL Gain (%) | XXII Price | XXII Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -30.37% | $1.33 | -43.16% | +12.79% |
| Sep 24, 2026 | $5.17 | -20.71% | $1.51 | -35.47% | +14.76% |
| Sep 23, 2026 | $7.31 | +12.12% | $2.34 | +0.00% | +12.12% |
| Sep 22, 2026 | $4.15 | -36.35% | $1.81 | -22.65% | -13.70% |
| Sep 21, 2026 | $4.10 | -37.12% | $1.77 | -24.36% | -12.76% |
| Sep 18, 2026 | $3.94 | -39.57% | $1.79 | -23.50% | -16.07% |
| Sep 17, 2026 | $3.97 | -39.11% | $1.77 | -24.36% | -14.75% |
| Sep 16, 2026 | $3.75 | -42.48% | $1.72 | -26.50% | -15.98% |
| Sep 15, 2026 | $5.34 | -18.10% | $1.80 | -23.29% | +5.19% |
| Sep 14, 2026 | $4.87 | -25.31% | $1.85 | -20.94% | -4.37% |
| Sep 11, 2026 | $5.43 | -16.72% | $1.99 | -14.96% | -1.76% |
| Sep 10, 2026 | $5.63 | -13.65% | $2.05 | -12.61% | -1.04% |
| Sep 09, 2026 | $5.98 | -8.28% | $2.13 | -8.97% | +0.69% |
| Sep 08, 2026 | $6.19 | -5.06% | $2.29 | -2.14% | -2.92% |
| Sep 04, 2026 | $6.04 | -7.36% | $2.45 | +4.70% | -12.06% |
Page 1 of 2